EUVIMEDSkopri EUVIMED
Crossref

The Regulatory Mechanism of Smilax China L. Saponins against Nonalcoholic Fatty Liver Is Revealed by Metabolomics and Transcriptomics

Cuiyu Li, Bin Fang, Yuanyuan Wei, Rou Mo, Xing Lin, Quanfang Huang

Journal of Oleo Science · 2024

DOI: 10.5650/jos.ess23167 ↗

At a glance

Journal article in Journal of Oleo Science, 2024. Written by Cuiyu Li and 5 co-authors. Institution: Metabolomics Laboratory, Guangxi Medical University. Major MEDLINE topics: Smilax, Saponins, Non-alcoholic Fatty Liver Disease, Insulin Resistance. Cited 4 times so far (Crossref); 33 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

This study was to investigate the effects of Smilax China L. saponins (SCS) on non-alcoholic fatty liver disease (NAFLD). Rats were fed a high-fat diet (HFD) for 8 weeks to induce NAFLD, followed by SCS treatment for 8 weeks. The effect of SCS on liver injury was observed by H&E staining and the regulative mechanism of SCS on lipid formation was exposed by detecting Oil red O, insulin resistance (IR), and fatty acids synthesis (FAS). Furthermore, transcriptomics and metabolomics were performed to analyze the potential targets. The experimental results indicated that SCS exerted a positive curative effect in alleviating HFD-induced overweight, hepatic injury, steatosis, and lipid formation and accumulation in rats, and the preliminary mechanism studies showed that SCS could alleviate IR, inhibit FAS expression, and reduce Acetyl-CoA levels. Besides, the integrative analysis of transcriptomics and metabolomics exposed the targets of SCS to regulate lipid production likely being the sphingolipid metabolism and glycerophospholipid metabolism pathways. This study demonstrates that SCS significantly ameliorates lipid metabolic disturbance in rats with NAFLD by relieving insulin resistance, inhibiting the FAS enzymes, and regulating the sphingolipid and glycerophospholipid metabolism pathways.

Subjects

MeSH terms (MEDLINE)

SmilaxSaponinsNon-alcoholic Fatty Liver DiseaseInsulin ResistanceMetabolomicsDiet, High-FatTranscriptomeLipid MetabolismAnimalsMaleRatsRats, Sprague-DawleySphingolipidsGlycerophospholipidsLiverDisease Models, Animal

Author keywords

glycerophospholipid metabolism pathwaymetabolomicsnon-alcoholic fatty liver disease (NAFLD)sphingolipid metabolism pathwaytranscriptomics

Substances

SaponinsSphingolipidsGlycerophospholipids

Authors and institutions

  • Metabolomics Laboratory, Guangxi Medical University.
  • The Pharmaceutical Department, Guangxi University of Chinese Medicine First Affiliated Hospital.

Cite

APA

Li, C., Fang, B., Wei, Y., Mo, R., Lin, X., & Huang, Q. (2024). The Regulatory Mechanism of Smilax China L. Saponins against Nonalcoholic Fatty Liver Is Revealed by Metabolomics and Transcriptomics. Journal of Oleo Science. https://doi.org/10.5650/jos.ess23167

Vancouver

Li C, Fang B, Wei Y, Mo R, Lin X, Huang Q. The Regulatory Mechanism of Smilax China L. Saponins against Nonalcoholic Fatty Liver Is Revealed by Metabolomics and Transcriptomics. Journal of Oleo Science. 2024. doi:10.5650/jos.ess23167

BibTeX
@article{Li2024,
  author = {Li, Cuiyu and Fang, Bin and Wei, Yuanyuan and Mo, Rou and Lin, Xing and Huang, Quanfang},
  title = {The Regulatory Mechanism of Smilax China L. Saponins against Nonalcoholic Fatty Liver Is Revealed by Metabolomics and Transcriptomics},
  journal = {Journal of Oleo Science},
  year = {2024},
  doi = {10.5650/jos.ess23167}
}
Start for free →